(Q42602375)
Statements
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis (English)
C Confavreux
P Vermersch
M Simu
C Sindic
R Hupperts
O Bajenaru
G Edan
L Grimaldi
I Marginean
R Medaer
I Pascu
J Pelletier
5 November 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference